BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Dentsply Sirona to Host Third Quarter 2021 Conference Call on November 4th

  DENTSPLY SIRONA Inc. announced today that the Company will be hosting an investor conference call and live webcast on Thursday, November 4, 2021 at 8:30 am ET to review its financial results.

  October 6, 2021

   · 

  1 min read
• Business

  Affinia Therapeutics Appoints Carole Faig to Board of Directors

  Affinia Therapeutics today announced the appointment of Carole Faig to the Affinia Therapeutics Board of Directors.

  October 6, 2021

   · 

  2 min read
• FDA

  4D Molecular Therapeutics Announces FDA Clearance of IND Application for 4D-150, a Dual-Transgene Intravitreal Gene Therapy for Patients with wet AMDInitiation of 4D-150

  4D Molecular Therapeutics announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug Application (IND) for 4D-150 for wet age-related macular degeneration (wet AMD).

  October 6, 2021

   · 

  7 min read
• Statera Biopharma, Inc. to Participate in the A.G.P. Biotech and Specialty Pharma Conference

  Statera Biopharma, Inc. announced today that the Company will participate in the Alliance Global Partners (A.G.P.) Biotech and Specialty Pharma Conference taking place October 13, 2021.

  October 6, 2021

   · 

  5 min read
• Business

  Roswell Biotechnologies Appoints Biotech Veteran Mike Aicher as Executive Chairman of Board of Directors

  Roswell Biotechnologies, Inc. announced today the appointment of Mike Aicher as executive chairman of its board of directors.

  October 6, 2021

   · 

  3 min read
• Mydecine to Present at the KCSA Psychedelics Virtual Investor Conference on October 14th

  Mydecine Innovations Group today announced that Josh Bartch , CEO of Mydecine, will participate in the KCSA Psychedelics Investor Conference

  October 6, 2021

   · 

  4 min read
• Biotech Bay

  BridgeBio Pharma to Host Virtual R&D Day on October 12, 2021

  BridgeBio Pharma, Inc. today announced that it will host its second R&D Day on Tuesday, October 12, 2021 , at 8:30 a.m. ET .

  October 6, 2021

   · 

  3 min read
• Drug Development

  PanTher Therapeutics Doses First Two Patients in Phase 1 Trial of PTM-101 for Treatment of Pancreatic Cancer

  PanTher Therapeutics announced today the dosing of the first two patients in its Phase 1 first-in-human clinical trial of PTM-101 for the treatment of pancreatic cancer.

  October 6, 2021

   · 

  3 min read
• Genetown

  Arch Therapeutics to Present at the LD Micro Main EventIn-Person Presentation on October 13, 2021

  Arch Therapeutics, Inc. will be featured as a presenting company at the LD Micro Main Event XIV. The conference is being held October 12th - 14th, 2021 at the Luxe Sunset Boulevard Hotel, Los Angeles, CA.

  October 6, 2021

   · 

  3 min read
• Drug Development

  Apexigen Announces First Patient Dosed in Phase 3 Pivotal Trial for BD0801, an Anti-VEGF Monoclonal Antibody, in Combination Therapy for Ovarian Cancer

  Apexigen, Inc. announced that Simcere Pharmaceutical Co. Ltd. has initiated a Phase 3 pivotal trial evaluating BD0801 in combination with chemotherapy for patients with recurrent, platinum-resistant ovarian cancer.

  October 6, 2021

   · 

  3 min read